Literature DB >> 12074771

Follicular thyroid carcinoma.

Philip I Haigh1.   

Abstract

Follicular carcinomas are rare thyroid malignancies that are difficult to diagnose preoperatively. Fine needle aspiration is an excellent diagnostic tool and should be the initial step in managing the solitary thyroid nodule. Follicular carcinoma cannot be diagnosed with certainty by cytologic features alone; the diagnosis rests on the histologic findings of blood vessel or tumor capsule invasion. Surgical resection is the primary option for treatment. The extent of thyroidectomy for optimal survival outcome has not been determined scientifically. The outcome is excellent in minimally invasive follicular carcinoma with lobectomy and isthmusectomy; it is difficult to argue that total thyroidectomy is necessary. In a low risk prognostic group, for tumors other than minimally invasive carcinoma, lobectomy and isthmusectomy or total thyroidectomy can be justified. However, if total thyroidectomy can be done safely with a minimum of complications, then it has definite advantages for staging, postoperative surveillance, treatment, and possibly a lower recurrence rate and better survival rate. For all patients at high risk of recurrence, total thyroidectomy is preferred.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074771     DOI: 10.1007/s11864-002-0034-z

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  28 in total

Review 1.  A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature.

Authors:  L D Thompson; J A Wieneke; E Paal; R A Frommelt; C F Adair; C S Heffess
Journal:  Cancer       Date:  2001-02-01       Impact factor: 6.860

2.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

3.  An expanded view of risk-group definition in differentiated thyroid carcinoma.

Authors:  B Cady; R Rossi
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

4.  Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.

Authors:  S I Sherman; J D Brierley; M Sperling; K B Ain; S T Bigos; D S Cooper; B R Haugen; M Ho; I Klein; P W Ladenson; J Robbins; D S Ross; B Specker; T Taylor; H R Maxon
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

5.  A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

Authors:  B R Haugen; F Pacini; C Reiners; M Schlumberger; P W Ladenson; S I Sherman; D S Cooper; K E Graham; L E Braverman; M C Skarulis; T F Davies; L J DeGroot; E L Mazzaferri; G H Daniels; D S Ross; M Luster; M H Samuels; D V Becker; H R Maxon; R R Cavalieri; C A Spencer; K McEllin; B D Weintraub; E C Ridgway
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

6.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; J R Goellner; J R Ebersold; C S Grant
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

Review 7.  The demise of follicular carcinoma of the thyroid gland.

Authors:  V A LiVolsi; S L Asa
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

8.  Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.

Authors:  T Taylor; B Specker; J Robbins; M Sperling; M Ho; K Ain; S T Bigos; J Brierley; D Cooper; B Haugen; I Hay; V Hertzberg; I Klein; H Klein; P Ladenson; R Nishiyama; D Ross; S Sherman; H R Maxon
Journal:  Ann Intern Med       Date:  1998-10-15       Impact factor: 25.391

9.  External radiotherapy in thyroid cancers.

Authors:  M Tubiana; E Haddad; M Schlumberger; C Hill; P Rougier; D Sarrazin
Journal:  Cancer       Date:  1985-05-01       Impact factor: 6.860

10.  Prognostic factors and risk group analysis in follicular carcinoma of the thyroid.

Authors:  A R Shaha; T R Loree; J P Shah
Journal:  Surgery       Date:  1995-12       Impact factor: 3.982

View more
  1 in total

1.  Needle track dissemination of follicular thyroid carcinoma following fine-needle aspiration biopsy: report of a case.

Authors:  Naotaka Uchida; Takako Suda; Tomoko Inoue; Yoshikazu Fujiwara; Kiyosuke Ishiguro
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.